Graft-versus-host disease, resulting from the T cells present in allogeneic hematopoietic stem cell (HSC) inoculums, can potentially be treated if a suicide gene has been introduced into the donor T cells. However, the diversity and functionality of the transfused T-cell population, including EBV-(EBV-T) and CMV-specific (CMV-T) CD8 þ T cells, which are particularly important for immunosuppressed individuals undergoing HSC transplants, are often modified by the gene transfer protocol. Here, we show that following polyclonal T-cell activation, EBV-T and CMV-T cells are preferentially transduced by oncoretroviral vectors, as compared to the bulk CD8 þ T-cell population. This preferential transduction is associated with higher surface levels of PiT-2, the receptor for the amphotropic envelope with which the virions are pseudotyped. Moreover, EBV-T and CMV-T cells proliferate more extensively as compared to bulk CD8 þ T cells. Thus, retroviralmediated transduction can be biased toward a given antigenic specificity, even under conditions of polyclonal stimulation.
Introduction
Treatment of graft-versus-host disease in the setting of allogeneic hematopoietic stem cell may be achieved by the ex vivo transfer of the herpes-simplex thymidine kinase (HSV-tk) gene in donor T cells, allowing these genemodified cells (GMC) to be sensitive to ganciclovir. [1] [2] [3] In our first clinical trial, GMC production required a 12-day ex vivo culture period including anti-CD3 T-cell polyclonal activation, retroviral-mediated transfer of the HSV-tk and neomycin phosphotransferase II (Neo-R) genes and a selection of GMC based upon their resistance to G418, a neomycin analog. 4 This protocol resulted in the transfusion of a population of T cells with a reduced anti-EBV response 5 but harboring a normal, or even enhanced, anti-CMV response. 6 This difference appears to be related to a differential susceptibility of these two populations to activation-induced cell death as well as a differential proliferation rate following CD3 stimulation. We further demonstrated that anti-EBV reactivity can be improved by activation of T cells via CD3/CD28 costimulation rather than by CD3 ligation alone, and by selecting GMC by virtue of a cell-surface marker encoded by the retroviral vector, such as a truncated low-affinity nerve growth factor receptor (DLNGFR), rather than by G418 selection. 5 Moreover, we previously demonstrated that the stimulation of T cells with alloantigen prior to transduction results in a preferential transduction of alloreactive T cells. 7 As division is required for oncoretrovirusmediated gene transfer, this bias in transduction is likely due to the fact that there is increased proliferation of alloreactive cells. 8 Such an observation was subsequently extended by Koehne et al 9 to other antigens such as EBV. In the present study, we demonstrate that antigenspecific stimulation might not always be the unique possibility to achieve preferential transduction. Indeed, after a polyclonal activation stimulus, anti-EBV (EBV-T) and anti-CMV (CMV-T) CD8 þ T cells are more susceptible to retroviral-mediated transduction than bulk CD8 þ cells.
Results and discussion
Using DLNGFR-coding vectors, we previously demonstrated that the frequency of EBV-T cells, as detected by reactivity against BMLF1 viral protein, was higher in the DLNGFR þ CD8 þ fraction than in the DLNGFRnegative CD8 þ fraction or even in cultured nontransduced, nonselected control cells. 5 These data strongly suggested that, although the cells were activated by a polyclonal stimulus prior to transduction, BMLF1-specific cells were preferentially transduced as compared to the bulk CD8 þ T-cell population. Similar observations were made for CMV-T cells, as monitored using pp65 tetramers. 6 To exclude an artefact due to immunomagnetic-based cell sorting of the transduced cells, we evaluated transduction efficiency of tetramer-positive and tetramer-negative cells prior to sorting by simultaneous staining for tetramer, DLNGFR and CD8 expression. To remain relevant with regard to our previous clinical trial, 3 gene transfer was performed after soluble CD3 monoclonal antibody (mAb) þ interleukin-2 (IL-2)-mediated T-cell activation (CD3/IL-2). Transduction efficiency was always higher in the EBV-T and CMV-T cells than in bulk CD8 þ T cells (Figure 1 ). This increased transduction efficiency was observed irrespective of the vector used (amphotropic or GALV-pseudotyped vector) or the transduction method (supernatant incubation or spin transduction, data not shown). When T cells were alternatively activated by CD3/CD28 beads (Xcyte Therapies Inc., Seattle, WA, USA) þ IL-2 (CD3/CD28/ IL-2), transduction efficiencies of bulk CD8 þ cells remained similar 5 while higher transduction efficiencies were also observed within EBV-T and CMV-T cells (data not shown).
The preferential transduction of EBV-T or CMV-T cells could be related to two mechanisms. One mechanism relates to a potentially higher surface expression of the receptor for the envelope used to pseudotype the retroviral vector (ie PiT-2 for amphotropic Env 11 ) on tetramer-positive cells. At day 0, Pit-2 þ cell frequency was significantly higher in tetramer-positive cells (BMLF1: 3.7771.48%; pp65: 0.9770.48%; n ¼ 8) than in the bulk CD8 þ cells (0.0870.04%; n ¼ 8; BMLF1 or pp65 versus CD8 þ : Po0.05, Wilcoxon's signed rank test). Upon CD3/IL-2 activation, the percentage of cells expressing PiT-2 was strongly increased in both tetramer-positive and tetramer-negative CD8 þ cells (Figure 2a) , suggesting an induction of Pit-2 expression rather than a preferential expansion of those cells expressing a high level of Pit-2. Pit-2 expression remained, at the time of retroviral-mediated transduction (day 3), significantly higher in tetramer-positive cells were activated by 10 ng/ml soluble CD3 mAb (OKT3, Jansen-Cilag, Levallois Perret, France) and 500 UI/ml recombinant human IL-2 (Cetus, Rueil Malmaison, France) 3, 4 and transduced at day 3 by spin transduction or incubation with retroviral vector-containing supernatants harboring either the DLNGFR-coding amphotropic SFCMM3 vector 10 (dashed lines, black symbols) or the gibbon ape leukemia virus (GALV)-pseudotyped DLNGFR-coding LNSN vector 5, 11 (full lines, white symbols). Cells were stained at day 7, as previously described 5 with an anti-human DLNGFR mAb for 20 min at 41C, then washed and incubated with goat-anti-mouse IgG-fluoroisothiocyanate (FITC) (Clinisciences, Montrouge, France) for 20 min at 41C. Cells were then stained with phycoerythrin (PE)-labeled HLA-A*0201 tetramers complexed with EBV-derived peptides (lytic protein BMLF1: GLCTLVAML; latent protein EBNA-3C: VLEETSVML) or CMV-derived peptides (IE1 early antigen: LLDFVRFMGV; pp65 late antigen: NLVPMVATV) and CD8-phycocyanin-5 (PC5) mAb (BeckmanCoulter Immunotech, Marseille, France) for 30 min at room temperature. 12, 13 After washing, cells were analyzed on a FACSCalibur flow cytometer using CellQuest software (Becton Dickinson). Analyses were performed after gating on the CD8 þ lymphocyte population. For each individual staining, the percentage of DLNGFR-positive cells is represented on the Y-axis for the bulk CD8 þ cells (CD8 þ ) and the tetramerspecific CD8 þ cells (EBV: BMLF1 þ and EBNA3C þ ; CMV: pp65 þ and IE1 þ ). Each symbol represents one independent experiment. CD3À CD56 þ NK cells represented o5% of GMC 6, 14 and were excluded from analysis by their low level of CD8 expression. Peripheral blood mononuclear cells were incubated (5 Â 10 6 cells/ml) for 10 min at room temperature in phosphate buffer saline (BioWhittaker, Emerainville, France) containing 5 mM 5-carboxyfluorescein diacetate succinimidyl ester (CFSE, Molecular Probes, Leiden, Netherlands). Cells were then washed once with human serum (EFS Bourgogne/FrancheComté, Besançon, France), then twice with phosphate buffer saline before CD3/IL-2 T-cell activation. At day 3, cells were stained with HLA-A*0201 tetramers and PC5-CD8 mAb. The graph represents the initial frequency of cells at day 0 that have subsequently undergone the indicated number (N) of cell divisions, calculated according to Wells et al. 16 Briefly, if a single T cell divides n times between day 0 and day 3, it will generate 2 n daughter cells. Thus, the absolute number of original, or precursor, T cells required to have generated these daughters is extrapolated by dividing the number of daughters under each division peak N by 2 n . The day-3 CFSE staining profiles of the corresponding experiment are shown for the pp65-specific cells (shaded area) and bulk CD8 þ cells (black line) in the upper right corner of the graph.
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than in the bulk CD8 þ T cells (Table 1) . Use of CD3/ CD28 beads induced similar levels of Pit-2 expression on bulk CD8 þ cells or tetramer-positive cells to those observed when activation was performed with CD3 mAbs (data not shown). The apparent relationship between expression of Pit -2, a type III sodium phosphate cotransporter, and activation state in T cells might be related to an increased requirement for exogenous phosphate uptake in dividing cells. 11, 17 Although the tools necessary to assess expression of the GALV receptor (Pit-1, another type III sodium phosphate cotransporter 11 ) are not available, it is possible that this receptor is also expressed at higher levels on EBV-T and CMV-T cells since preferential transduction was also observed with a GALV-pseudotyped vector.
The second mechanism that may have contributed to the preferential transduction of EBV-T and CMV-T cells could be related to their proliferative potential. Using CFSE in order to study precisely proliferation and generation of daughter cells, we found that there was increased proliferation of EBV-T and CMV-T cells as compared with bulk CD8 þ cells following CD3/IL-2 stimulation. A CFSE staining was performed at day 0, before CD3/IL-2 activation, followed by a tetramer costaining performed at day 3. Our data demonstrate ( Table 2 ) that the fraction of cells having undergone at least two cell divisions was significantly higher in BMLF1-and pp65-specific cells than in bulk CD8 þ cells. One representative experiment is shown in Figure  2b , together with its CFSE profiles of bulk CD8 þ cells and CMV-T cells. Moreover, the maximum number of cell divisions at this time point was also significantly higher in BMLF1-and pp65-specific cells than in bulk CD8 þ cells (Table 2) , resulting in an increased proportion of cells that are sensitive to oncoretroviral-mediated transduction. Similar results were observed when using CD3/ CD28 beads instead of CD3 mAbs (data not shown).
In conclusion, we show that polyclonal stimulation results in a biased retroviral-mediated transduction of certain T cells. Knowledge of such skewing in antigen specificity after retrovirus-mediated transduction will be important for the design of cellular immunotherapy approaches and benefit the targeting of T cells specific for CMV and EBV antigens. It remains to be determined whether such a preferential transduction is also observed in T cells specific for other antigens and can be extended to specific T-cell subsets. 72.5* (6.5)** 74.5* (6)*** a Cells were stained by CFSE at day 0, then CD8 mAb and tetramers at day 3 after CD3/IL-2 activation, as described in the legend of Figure 2 . Data are expressed as the percent of cells at day 0, within the bulk CD8+, BMLF1-and pp65-specific subsets, that will subsequently divide twice or more between day 0 and day 3 of culture. Values within parentheses represent the maximum number of cell divisions detectable at day 3. b Detailed day-0 precursor frequencies, for each cell division, and CFSE profile of experiment #6 are shown in Figure 2b . *Po0.001 versus bulk CD8+ cells (paired t-test). **P ¼ 0.007 versus bulk CD8+ cells (paired t-test). ***P ¼ 0.03 versus CD8+ cells (Wilcoxon's signed rank test).
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